Month: June 2025

  • MENA content deal renewal from Sony Pictures Entertainment & beIN

    MENA content deal renewal from Sony Pictures Entertainment & beIN

    beIN Media Group has extended its longstanding content agreement with Sony Pictures Entertainment (SPE), securing exclusive multi-year rights to a broad portfolio of acclaimed television series and films which will come to beIN’s audiences across the Middle East and North Africa (MENA), and Turkey.

    As part of the renewed deal, beIN will continue to hold first and second window rights to several film titles from SPE’s diverse library.

    In the Middle East, content will be available in both Arabic and English across beIN’s entertainment channels, beIN ON DEMAND, and on its OTT platforms, TOD and beIN CONNECT. In Turkey, content will be available in English and Turkish via Digiturk’s entertainment channels, as well as TOD and beIN CONNECT.

    “We are proud to extend our valued relationship with Sony Pictures Entertainment — a creative powerhouse that continues to captivate global audiences,” said Esra Özaral Altop, Chief Entertainment Content Officer, beIN Media Group. “This renewed agreement not only reflects our dedication to curating premium entertainment for viewers across MENA and Türkiye, but also marks a new chapter in strengthening our entertainment portfolio.”

    SPE’s upcoming slate includes highly anticipated titles such as I Know What You Did Last Summer, 28 Years Later, Until Dawn, and Karate Kid: Legends.

    The agreement could also allow audiences to watch recent hits like Venom: The Last Dance, Kraven the Hunter, Saturday Night, the Oscar-winning I’m Still Here, and Paddington in Peru coming to beIN’s audiences.

    For television series, the agreement covers fan-favourites including Outlander (Seasons 1-8), The Good Doctor (Seasons 1-7), Twisted Metal (Season 1-2), and anime hits from Crunchyroll: Jujutsu Kaisen and My Hero Academia (Seasons 1-2).

    “Our passion at Sony Pictures is to bring great stories to great audiences, and our friends and partners at beIN remain the perfect home to bring this plethora of amazing content to audiences across MENA and Turkey,” said Mark Young, EVP, Distribution & Networks, EMEA, Sony Pictures Television. “We are thrilled that their wide audiences will continue to enjoy the wealth of content from SPE’s future slate as well as our vast library of beloved classics, and we join them in being incredibly pleased to make this announcement today”

    First signed in 2021, the renewed agreement aims to build on the longstanding collaboration between beIN and SPE, while underscoring beIN’s position as a global entertainment network. Campaign

  • Disney fires hundreds in TV and film as industry problems persist

    Disney fires hundreds in TV and film as industry problems persist

    Media company Walt Disney Co is laying off several hundred employees across its film and television divisions, highlighting the downturn in the entertainment industry.

    The layoffs, which began on Monday, affect staff in marketing, publicity, casting, development, and corporate finance, according to media reports. This round follows the 200 job cuts at Disney’s ABC and entertainment TV networks in March. Overall, the company has cut more than 8,000 jobs in recent years as part of efforts to boost profitability.

    Hollywood restructures as cost pressures mount
    Hollywood has been in cost-cutting mode for several years, with production and employment steadily declining, reports Bloomberg. Studios have scaled back film releases to improve profitability, especially as theatre attendance remains below pre-pandemic levels. Meanwhile, consumers are cancelling cable subscriptions in favour of streaming services, reducing advertising and distribution revenue for traditional TV channels.

    This shift is driving a major industry reorganisation. Comcast reportedly plans to spin off most of its cable channels, including MSNBC, USA, and CNBC, by year-end. Warner Bros. Discovery has restructured internally to separate its studio and cable operations, potentially paving the way for divesting the latter. Paramount Global also anticipates further cuts as it moves forward with a merger with independent studio Skydance Media.

    Disney’s strategic decisions and financial outlook
    Disney had considered selling its TV networks, including ABC, but chose to retain them, according to reports. In February 2023, it cut 7,000 jobs, aiming to save $5.5 billion, later raising the target to $7.5 billion. Industry rivals have also executed thousands of layoffs.

    At the close of its last financial year in September, Disney employed approximately 233,000 people, with 76 per cent working full time. In its latest earnings report released in May, the company surpassed Wall Street forecasts, driven by an unexpected surge in Disney+ streaming subscriptions and robust performance from its theme parks. Business Standard

  • EchoStar bond issues worsen as Dish Network fails to pay interest payments

    EchoStar bond issues worsen as Dish Network fails to pay interest payments

    EchoStar Corp., the wireless and pay-TV operator controlled by billionaire Charlie Ergen, has decided to skip interest payments on three bonds after a similar act late last week.

    A total of $183 million interest payments due Monday on several bonds related to its pay-TV operator unit Dish Network Corp. will not be paid, according to a regulatory filing. The company cited “uncertainty” raised by the Federal Communications Commission review. The company has been tied up in a regulatory probe over its compliance with obligations to build a nationwide 5G network.

    EchoStar’s shares fell 3.6% in postmarket trading on Monday. Dish’s 7.75% note due 2026 dropped over 1 cent to 84 cents on the dollar, according to Trace data.

    The company has a 30-day grace period to make the interest payment. The company is skipping the payment to “allow time for the FCC to provide the relief requested,” it said.

    Ergen was locked in a dispute with Dish’s bondholders last year, after a group of creditors rejected a bond-exchange offer that would have helped facilitate a proposed acquisition by rival DirecTV. The deal would have required lenders to take a steep haircut on the debt that they owned. Bloomberg

  • Delhi High Court permits Star India to quickly forbid downloaded apps & sites

    Delhi High Court permits Star India to quickly forbid downloaded apps & sites

    Taking a significant step to combat online piracy, the Delhi High Court has issued an injunction order – which is considered a stronger version of the traditional Dynamic + injunction.

    So that fake websites and mobile apps illegally streaming the ongoing IPL and other cricket matches can be blocked forever.

    Justice Saurabh Banerjee gave this unique order in a case filed by Star India Private Limited, which has exclusive streaming rights for high-profile cricket tournaments including the Indian Premier League (IPL) and India’s tour of England. The court restrained the defendants from infringing the rights of Star India and allowed relief at the present time against websites and mobile applications involved in unauthorized broadcasting, even if it is discovered during legal proceedings.

    “In the age of new technology, today it has become very easy and convenient for infringers to create alpha-numeric/mirror/redirect variants of infringing websites…In such circumstances, this Court has repeatedly held that there is a need for relief in real time,” – Delhi High Court in Star India Pvt Ltd & Ors vs JioLive TV & Ors (2023)

    This is the first time that the Delhi High Court has granted such legal relief to a fake mobile application, marking a significant development in the fight against digital piracy. In the previous case, Star India Pvt Ltd vs https://crichdplayer.org & Ors (2025), the Court had granted injunction in real time, but only against fake websites, not against mobile apps.

    However, in the present case, the Court observed:

    “There is neither any obstruction nor any harm caused…If the same relief as granted in the cases of fake websites is extended to fake mobile applications as well…then the manner of use/dissemination activity is hardly a matter of concern.”

    The suit originally involved four known defendants, with Star India also naming several unknown rogue websites. As the case progressed, Star India filed seven interlocutory applications covering three fake mobile applications and 16 fake domains/URLs/UIs.

    The timing of the case was significant, as Star India highlighted the challenge of discovering new fake entities in real time during court holidays, particularly during the IPL and other major tournaments. The Court accepted this argument, and acknowledged the difficulty of repeatedly approaching the Court for new relief.

    It recognised the evolving nature of piracy, where infringing platforms – both websites and apps – become instantly visible during time-sensitive events such as live cricket matches.

    “Superior injunctions open an additional avenue for plaintiffs to obtain present-day relief against the infringing activities of ‘fictitious’ defendants, regardless of the modus operandi,”
    — Delhi High Court

    By granting this present-day blocking power, the Court has strengthened the enforcement of intellectual property rights in India’s sports broadcasting industry, sending a strong signal against digital piracy through both web platforms and mobile applications.

    Case no.: CS(COMM) 108/2025

    Case title: Star India Pvt Ltd v. IPTV Smarter Pro & Ors.

    Appearance: Mr. Sidharth Chopra, Mr. Yatinder Garg, Ms. Disha Sharma and Ms. Rimjhim Tiwari and Ms. Isha Singh, Advs for Plaintiff; Mr. Avish Sharma, Adv. for D-1, 4 & 36. Ms. Mrinal Ojha, Mr. Debarshi Dutta, Mr. Arjun Mookerjee, Ms. Nikita Rathi and Mr. Nikhil Gupta, Advs. for D-7.  Court Book

  • Keysight must sell its tech assets before the US will buy Spirent

    Keysight must sell its tech assets before the US will buy Spirent

    The US government will require Keysight Technologies to divest three of Spirent Communications’ businesses to resolve antitrust concerns before it buys the British company, a purchase originally valued at $1.5 billion.

    D.C., federal court, the US Department of Justice said the divested assets include Spirent’s high-speed ethernet testing, network security testing, and radio frequency channel emulation businesses.

    Keysight said in March it planned to sell those businesses to Viavi Solutions, once known as JDS Uniphase, for as much as $425 million in cash.

    The Justice Department said Keysight and Spirent together account for 85% of the high-speed ethernet testing market, more than 60% of the network security market, and more than 50% of radio frequency channel emulation.

    It said a merger without the divestitures might substantially lessen competition and harm customers.

    Based in Santa Rosa, California, Keysight agreed in March 2024 to buy Crawley, U.K.-based Spirent for 1.16 billion British pounds, now about $1.57 billion.

    Viavi had agreed earlier that month to buy Spirent, but was outbid by Keysight. Reuters

  • AI tool is introduced by the US FDA to reduce the length of scientific reviews

    AI tool is introduced by the US FDA to reduce the length of scientific reviews

    The US Food and Drug Administration (FDA) launched Elsa, a generative Artificial Intelligence (AI) tool designed to help employees—from scientific reviewers to investigators—work more efficiently. This innovative tool modernizes agency functions and leverages AI capabilities to better serve the American people.

    “Following a very successful pilot program with FDA’s scientific reviewers, I set an aggressive timeline to scale AI agency-wide by June 30,” said FDA Commissioner Marty Makary, M.D., M.P.H. “Today’s rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers.”

    Built within a high-security GovCloud environment, Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff.

    “Today marks the dawn of the AI era at the FDA with the release of Elsa, AI is no longer a distant promise but a dynamic force enhancing and optimizing the performance and potential of every employee,” said FDA Chief AI Officer Jeremy Walsh. “As we learn how employees are using the tool, our development team will be able to add capabilities and grow with the needs of employees and the agency.”

    The agency is already using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations, and identify high-priority inspection targets.

    Elsa is a large language model–powered AI tool designed to assist with reading, writing, and summarizing. It can summarize adverse events to support safety profile assessments, perform faster label comparisons, and generate code to help develop databases for nonclinical applications. These are just a few examples of how Elsa will be used across the enterprise to improve operational efficiency.

    The introduction of Elsa is the initial step in the FDA’s overall AI journey. As the tool matures, the agency has plans to integrate more AI in different processes, such as data processing and generative-AI functions to further support the FDA’s mission.

    Prioritizing efficiency and responsibility, the FDA launched Elsa ahead of schedule using an all-center approach. Leaders and technologists across the agency collaborated, demonstrating the FDA’s ability to transform its operations through AI. Reuters

  • Up 58% from the April low, Bharti Hexacom soars to its highest level ever

    Up 58% from the April low, Bharti Hexacom soars to its highest level ever

    Shares of Bharti Hexacom hit a new high of ₹1,933.45, as they rallied 4.5 per cent on the BSE in Tuesday’s intra-day trade in an otherwise weak market on a healthy business outlook.

    The stock price of telecom services provider was quoting higher for the seventh straight trading day, surging 16 per cent during this period. It has bounced back 58 per cent from its three-month low of ₹1,225 touched on April 7, 2025.

    At 10:22 AM; Bharti Hexacom was quoting 3 per cent higher at ₹1,908.35, as compared to 0.07 per cent rise in the BSE Sensex.

    Bharti Hexacom’s Q4 results
    In the January to March 2025 quarter, the company’s consolidated revenues came in at ₹47,876 crore and this was impacted by a decline in B2B segment, which was in line with what the company guided last quarter to focus on quality revenues. India revenues, excluding Indus, came in at ₹33,100 crore. Earnings before interest, tax, depreciation and amortisation (Ebitda) margins came in at 50.7 per cent, this is an improvement of 1.4 per cent. The company said it prepaid another tranche of high cost Department of Telecommunications (DoT) spectrum debt of ₹5,985 crore.

    Healthy business outlook
    Analysts expect Bharti Hexacom’s Ebitda margin to further improve, driven by strong average revenue per user (ARPU) growth on account of tariff hikes, Bharti’s premiumisation strategy and cost optimisation via its ‘war on waste’ initiative.

    Analysts at JM Financial Institutional Securities believe India’s wireless business tariff hikes are likely to be more frequent, going forward, given the consolidated industry structure and higher ARPU requirement for Jio also to justify significant 5G capex and given Jio’s potential IPO.

    ARPU growth aided by likely moderation in capex will continue to drive Bharti Heaxacom’s FCF growth, enabling it to get to net cash by FY29; this will also aid in accretion in equity value. The brokerage firm sees Bharti Hexacom as a midcap pure-play on the structural wireless ARPU growth story.

    Bharti Hexacom provides a pure-play exposure to Bharti Airtel’s fast-growing India wireless and home broadband segments. Given the relatively lower penetration of mobile and fixed broadband in Bharti Hexacom’s circles, its growth prospects are slightly better than Airtel’s.

    Given lower teledensity and lower internet penetration in Hexacom circles (vs. pan-India), analysts believe Hexacom can potentially grow a few percentage points faster than Airtel on both subscribers and ARPU. Further, with significantly lower penetration of fixed broadband in Hexacom’s circles and the recent ramp-up of Fixed Wireless Access (FWA) offerings, analysts believe Hexacom’s wired broadband business could also grow at a faster clip.

    Motilal Oswal Financial Services believes Bharti Hexacom should command a premium to Airtel, given its slightly higher growth, better RoCEs, and lower capital misallocation concerns, and ascribe a DCF-based Jun’27E EV/EBITDA of 14.5x to Bharti Hexacom. However, currently, the stock is trading above brokerage firm’s target price of ₹1,900 per share. Business Standard

  • US funding sanctions affects African malaria prevention initiatives

    US funding sanctions affects African malaria prevention initiatives

    The “catastrophic” freeze on US funding for malaria has halted prevention programmes across Africa and also threatens to stall advances in genomic research, says Jane Carlton, director of the Johns Hopkins Malaria Research Institute.

    The US President’s Malaria Initiative (PMI) is one of numerous USAID-supported programmes to see its funding terminated under US President Donald Trump’s sweeping reforms this year.

    From eco-friendly bacterial pellets that kill mosquito larvae, to gene-drive mosquitoes that suppress wild populations, scientists are developing an arsenal of promising new technologies to combat malaria.

    “But without sustained funding, even the best tools stall”, says Carlton, warning that a retreat from funding could jeopardise decades of progress. SciDev.Net

  • EU should restrict procurement contracts for Chinese MedTech companies

    EU should restrict procurement contracts for Chinese MedTech companies

    The European Union is set to curb Chinese medical device manufacturers’ access to public procurement contracts in the bloc, according to a person familiar with the matter.

    EU countries are due to vote on the proposed measure as early as Monday, said the person, who spoke on condition of anonymity to discuss private deliberations.

    The move, if backed by member states, would be the first action taken by the EU based on its International Procurement Instrument, a 2022 law that’s meant to promote reciprocity in access to public procurement markets. Implementation of the restrictions could open a new front with China, just as the EU seeks to strike a balance in its relationship with Beijing while navigating US President Donald Trump’s tariff war.

    A spokesperson for the European Commission, the EU’s executive arm, didn’t immediately reply to a request for comment.

    The EU launched an investigation into China’s procurement of medical devices last April, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported.

    Beijing’s focus on local and state-oriented procurement in medical technologies has increased in recent years, as authorities across the country included strict domestic product requirements for many categories of device. The shift turned a €1.3 billion trade deficit in these goods for China in 2019 into a €5.2 billion surplus just one year later, according to data cited in an EU report published last April. The focus of the investigation wasn’t to reverse that trend but to enable fair competition.

    The EU has long argued that Beijing has been pushing market-distorting measures and practices to implement its “Made in China” policy and its target of achieving 85% domestic market share for Chinese companies producing “core medical device components” by 2025. The target is 70% for higher-end devices.

    The IPI allows the commission to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from procurement contracts. Bloomberg

  • Hospital OPDs in India have seen a triple rise in tourists amid the COVID-19 pandemic

    Hospital OPDs in India have seen a triple rise in tourists amid the COVID-19 pandemic

    It’s never a dull moment in hospitals across India and with Covid-19 infections rising across the country, hospitals are seeing a rise in footfalls in the outpatient departments (OPDs). India’s coronavirus burden is rising on a daily basis with many patients rushing to the hospital, fearing the worst.

    Several states in India are recording a spike in coronavirus infections — on Monday (June 2), India’s active Covid-19 cases stand at 3,961 with 203 new cases being added only on Sunday. That’s not it; the country is also recording a rise in Covid-related deaths — four have been reported since Sunday.

    So, what’s going on? How bad is the situation?

    India’s Covid burden keeps rising
    As of Monday (June 2), the country’s active Covid cases are 3,961 — more than a 15-fold increase in just 10 days, according to the data from the Ministry of Health and Family Welfare. Health authorities attribute the rapid increase to the emergence of new, more transmissible Omicron sub-variants, specifically NB.1.8.1 and NF.7 , predominantly affecting southern and western India.

    Data shows that the most cases have been detected in Kerala — 1,435 cases — whereas Maharashtra comes in second with 506 Covid cases. Delhi with 483 infections comes in third while Gujarat recorded 338 cases, coming in fourth. West Bengal (331), Karnataka (253), Tamil Nadu (189) and Uttar Pradesh (157) are the other states where Covid infections are being recorded in high numbers.

    Along with the rising infections, Covid deaths are also being reported in the country. Four deaths — one each in Delhi, Kerala, Maharashtra, and Tamil Nadu have been reported across the country in the past 24 hours.

    Indian Council of Medical Research (ICMR) Director General Dr Rajiv Bahl was quoted as telling the media that the rise in cases began in southern states, followed by western and now northern regions. The ICMR is closely monitoring the situation through the Integrated Disease Surveillance Programme (IDSP), he said.

    He further added, “The variants we have sequenced from South and West India are not much severe. Four variants have been discovered — LF.7 series, XFG series, JN.1 series and NB.1.8.1 series in the same order. We are sequencing the samples from other areas to check for more new variants… The cases are not very severe and people should not worry, but only stay vigilant.”

    OPD admissions in hospitals increase
    And as a result of the increasing Covid cases, patient footfall at OPDs is rising by at least three to four times. Dr Pradeep Bajad, senior consultant, pulmonary, critical care, and sleep medicine at Faridabad-based Amrita Hospital, told News18, “At present, we are not seeing a surge in ICU admissions due to Covid-19 directly. However, we are witnessing a marked increase in OPD footfall, with patient visits increasing by nearly three to four times in the past 10 days.”

    Dr Suranjit Chatterjee, senior consultant, internal medicine at Indraprastha Apollo Hospitals, also noted a rise in patients visiting the OPD. He also stated that most of those who are visiting the OPD are complaining of fever, sore throat, and upper respiratory symptoms, which he calls routine and manageable.

    Dr Arup Halder, consultant pulmonologist at CMRI Hospital, Kolkata, also said that there was a significant rise in OPD consultations. People with fever and cold-like symptoms are walking in to get themselves checked out, he was quoted as saying.

    The rising infections have also got hospital authorities on high alert; they are ramping up preventive measures such as increased Covid testing and preparation of hospital beds. In fact, many hospitals across the country are preparing isolation wards amid the Covid spike. For instance, in Haryana, officials have been asked to ensure hospitals establish dedicated flu corners and maintain adequate isolation beds, oxygen supplies, PPE kits, N95 masks, antibiotics, and testing kits.

    At the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, special wards for Covid-19 patients, including ICU beds and high-dependency units, have been activated. A similar picture is prevalent in Karnataka wherein hospitals are preparing bigger and better isolation wards.

    Covid symptoms to watch out for
    Doctors note that most of the patients being diagnosed with Covid have the usual symptoms — fever, sore throat, cough, cold, headache, body ache and fatigue. However, this time there’s one specific symptom that could help patients discern if they are infected and that’s having diarrhoea, especially watery diarrhoea.

    “Many are coming in with diarrhoea. Painless, watery stools for a day or two followed by severe lethargy or fatigue. Lethargy can persist for weeks post-discharge from the hospital. So, any patient who presents with unexplained diarrhoea, check for Covid-19,” Dr Chatterjee was quoted as telling News18.

    Doctors note that this change may be due to the virus’s altered behaviour in the body or its interaction with the gut’s immune system.

    Dr Charudatt Vaity, director of critical care at Fortis Hospital Mulund, also noted that an increasing number of patients with runny diarrhoea were testing positive for Covid.

    Doctors calls for extra vigilance
    But despite the rise in cases, doctors are of the opinion that the situation is still under control and that there is no need to panic. However, medical experts have called for an increase in vigilance. Dr Sanjay Jain, dean research, PGIMER, said, “Most new variant cases are mild, but vigilance is essential, especially to protect the vulnerable.”

    Even Union Minister of State for Health and AYUSH (Independent Charge), Prataprao Jadhav, assured that the Centre is fully prepared to handle any situation that may arise. “Both our Central Health Department and the AYUSH Ministry are fully alert and closely monitoring the situation across all states. We have spoken with the respective Health and AYUSH Secretaries, as well as other concerned ministers,” Jadhav was quoted as telling news agency ANI.

    Soumya Swaminathan , former chief scientist at the World Health Organisation (WHO), also echoed similar sentiments. She has urged the public to stay cautious but not to panic. Speaking to News18, she said that the current trends do not indicate a return to the devastating waves of 2020 or 2021.

    “Covid or SARS-CoV-2, which is the virus, is another respiratory virus, like the many others that are circulating amongst us human beings in the world today. It has been around for five years now. It’s, of course, constantly mutating and changing, like other viruses,” she said.

    She further added, “What you’re seeing now is a mild disease mostly. Even though people are testing and reporting positivity, you find that hospitalisations are rare.” FIRSTPOST